All Stories

  1. Essential Oils as Alternative Antimicrobials: Current Status

    Article • Recent Advances in Anti-Infective Drug Discovery, April 2024, Bentham Science Publishers

    DESH DEEPAK SINGH, Dr Debaprasad Parai

  2. Evaluation of Antibacterial and Antibiofilm Activities of Fennel Seed Extract Against Methicillin-resistant Staphylococcus aureus

    Article • Current Bioactive Compounds, February 2024, Bentham Science Publishers

    Dr Debaprasad Parai, DESH DEEPAK SINGH

  3. Suspected human anthrax outbreak investigation in a tribal village of Koraput, India, 2021

    Article • Public Health Challenges, December 2023, Wiley

    Dr Debaprasad Parai, Debdutta Bhattacharya

  4. Investigation of human anthrax outbreak in Koraput district of Odisha, India

    Article • Travel Medicine and Infectious Disease, November 2023, Elsevier

    Debdutta Bhattacharya, Dr Debaprasad Parai

  5. SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey

    Article • Rheumatology International, October 2023, Springer Science + Business Media

    Debdutta Bhattacharya, Dr Debaprasad Parai

  6. Hepatitis B virus infection among the tribal and particularly vulnerable tribal population from an eastern state of India: Findings from the serosurvey in seven tribal dominated districts, 2021–2022

    Article • Frontiers in Microbiology, March 2023, Frontiers

    Dr Debaprasad Parai, Debdutta Bhattacharya

  7. Perception and determinants leading to antimicrobial (mis)use: A knowledge, attitude, and practices study in the rural communities of Odisha, India

    Article • Frontiers in Public Health, January 2023, Frontiers

    Dr Debaprasad Parai, Debdutta Bhattacharya

  8. Association of Probiotics and Prebiotics with Human Microbiome and the Functioning of Immune System

    Article • January 2023, Springer Science + Business Media

    Dr Debaprasad Parai

  9. Seroprevalence of human brucellosis among the tribal and non-tribal population residing in an eastern state of India: Findings from the state-wide serosurvey

    Article • Frontiers in Microbiology, November 2022, Frontiers

    Dr Debaprasad Parai, Debdutta Bhattacharya

  10. Seroprevalence of SARS-CoV-2 in patients with rheumatic diseases on disease modifying antirheumatic drugs and /or immunosuppressive medications from India: a multicentric study

    Article • October 2022, Research Square

    Dr Debaprasad Parai

  11. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance

    Article • npj Biofilms and Microbiomes, August 2022, Springer Science + Business Media

    Dr Debaprasad Parai, Debdutta Bhattacharya

  12. Scrub typhus seroprevalence from an eastern state of India: findings from the state-wide serosurvey

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, August 2022, Oxford University Press (OUP)

    Dr Debaprasad Parai, Debdutta Bhattacharya

  13. Dynamicity and persistence of severe acute respiratory syndrome coronavirus-2 antibody response after double dose and the third dose with BBV-152 and AZD1222 vaccines: A prospective, longitudinal cohort study

    Article • Frontiers in Microbiology, August 2022, Frontiers

    Dr Debaprasad Parai, Debdutta Bhattacharya

  14. Assessment of socio-behavioural correlates and risk perceptions regarding anthrax disease in tribal communities of Odisha, Eastern India

    Article • BMC Infectious Diseases, January 2022, Springer Science + Business Media

    Debdutta Bhattacharya, Dr Debaprasad Parai

  15. Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India

    Article • Epidemiology and Infection, January 2022, Cambridge University Press

    Debdutta Bhattacharya, Dr Debaprasad Parai

  16. Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave

    Article • The Indian Journal of Medical Research, January 2022, Medknow

    Dr Debaprasad Parai, Debdutta Bhattacharya

  17. Trend in seroprevalence of SARS-CoV-2 (IgG antibody) among tribal-dominated population: Findings from Jharkhand, India

    Article • The Indian Journal of Medical Research, January 2022, Medknow

    Dr Debaprasad Parai, Debdutta Bhattacharya

  18. Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines

    Article • Frontiers in Medicine, December 2021, Frontiers

    Debdutta Bhattacharya, Dr Debaprasad Parai

  19. Quorum Sensing Inhibitors from Natural Products: A New Anti-infective Approach

    Article • November 2021, Bentham Science Publishers

    Dr Debaprasad Parai

  20. Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection

    Article • Travel Medicine and Infectious Disease, November 2021, Elsevier

    Debdutta Bhattacharya, Dr Debaprasad Parai

  21. COVID-19 in children in Odisha state, India: a retrospective review

    Article • BMJ Paediatrics Open, November 2021, BMJ

    Debdutta Bhattacharya, Dr Debaprasad Parai

  22. SARS-CoV-2 IgG antibody responses in rt-PCR-positive cases: first report from India

    Article • Access Microbiology, October 2021, Society for General Microbiology

    Dr Debaprasad Parai

  23. Breakthrough SARS‐CoV‐2 infections among BBV‐152 (COVAXIN®) and AZD1222 (COVISHIELD TM ) recipients: Report from the eastern state of India

    Article • Journal of Medical Virology, October 2021, Wiley

    Debdutta Bhattacharya, Dr Debaprasad Parai

  24. IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection

    Article • Infection, July 2021, Springer Science + Business Media

    Debdutta Bhattacharya, Dr Debaprasad Parai

  25. Pooled testing for SARS‐CoV‐2 infection in an automated high‐throughput platform

    Article • Journal of Clinical Laboratory Analysis, June 2021, Wiley

    Debdutta Bhattacharya, Dr Debaprasad Parai

  26. Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies

    Article • Journal of Virological Methods, June 2021, Elsevier

    Debdutta Bhattacharya, Dr Debaprasad Parai

  27. One Health approach for elimination of human anthrax in a tribal district of Odisha: Study protocol

    Article • PLoS ONE, May 2021, PLOS

    Debdutta Bhattacharya, Dr Debaprasad Parai

  28. Effect of a single-dose of BBV-152 and AZD1222 on Spike antibody titre among healthcare workers previously infected with SARS-CoV-2

    Article • May 2021, Research Square

    Dr Debaprasad Parai

  29. Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India

    Article • Scientific Reports, May 2021, Springer Science + Business Media

    Debdutta Bhattacharya, Dr Debaprasad Parai

  30. IgG antibody response against Nucleocapsid and Spike protein post SARS-CoV-2 infection

    Article • May 2021, Research Square

    Dr Debaprasad Parai

  31. Seroprevalence of IgG antibody against SARS-CoV-2 among health care workers of anaesthesia departments from various hospital settings in India

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Debdutta Bhattacharya, Dr Debaprasad Parai

  32. A qualitative exploratory study using One Health approach for developing an intervention package for elimination of human anthrax in an endemic district of Odisha, India

    Article • The Indian Journal of Medical Research, January 2021, Medknow

    Debdutta Bhattacharya, Dr Debaprasad Parai

  33. Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys

    Article • Epidemiology and Infection, January 2021, Cambridge University Press

    Debdutta Bhattacharya, Dr Debaprasad Parai

  34. Biofilm: A Challenge to Overcome in Wound Healing

    Article • January 2021, Springer Science + Business Media

    Dr Debaprasad Parai

  35. Saliva for diagnosis of SARS‐CoV‐2: First report from India

    Article • Journal of Medical Virology, December 2020, Wiley

    Sidhartha Giri, Debdutta Bhattacharya, Dr Debaprasad Parai

  36. A rare hetero-bimetallic Zn(II)/Ca(II) Schiff base complex: Synthesis, crystal structure, DFT, molecular docking and unveiling antimicrobial activity

    Article • Journal of Molecular Structure, December 2020, Elsevier

    Dr Debaprasad Parai

  37. Antimicrobial Peptides: An Approach to Combat Resilient Infections

    Article • Current Drug Discovery Technologies, September 2020, Bentham Science Publishers

    Dr Debaprasad Parai, Pia Dey

  38. DFT investigations of linear Zn3-type complex with compartmental N/O-donor Schiff base: Synthesis, characterizations, crystal structure, fluorescence and molecular docking

    Article • Journal of Molecular Structure, June 2020, Elsevier

    Dr Debaprasad Parai

  39. Naringin sensitizes the antibiofilm effect of ciprofloxacin and tetracycline against Pseudomonas aeruginosa biofilm

    Article • International Journal of Medical Microbiology, April 2020, Elsevier

    Dr Debaprasad Parai

  40. Antibiofilm and antivirulence property of reserpine.

    Article • Biofouling, February 2018, Taylor & Francis

    Dr Debaprasad Parai, Pia Dey

  41. Andrographolide induces oxidative stress-dependent cell death in unicellular protozoan parasite Trypanosoma brucei

    Article • Acta Tropica, December 2017, Elsevier

    Dr Debaprasad Parai

  42. Attenuation of Pseudomonas aeruginosa quorum sensing, virulence and biofilm formation by extracts of Andrographis paniculata

    Article • Microbial Pathogenesis, December 2017, Elsevier

    Dr Debaprasad Parai

  43. Bacterial biofilm eradication by Bacoside A

    Article • Canadian Journal of Microbiology, February 2017, Canadian Science Publishing

    Dr Debaprasad Parai

  44. Andrographolide: antibacterial activity against common bacteria of human health concern and possible mechanism of action

    Article • Folia Microbiologica, January 2017, Springer Science + Business Media

    Dr Debaprasad Parai